Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers.
J Hematol Oncol. 2023 Dec 12;16(1):117. doi: 10.1186/s13045-023-01516-3.
J Hematol Oncol. 2023.
PMID: 38087365
Free PMC article.
Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity.
Dheilly E, Majocchi S, Moine V, Didelot G, Broyer L, Calloud S, Malinge P, Chatel L, Ferlin WG, Kosco-Vilbois MH, Fischer N, Masternak K.
Dheilly E, et al. Among authors: majocchi s.
Antibodies (Basel). 2018 Jan 3;7(1):3. doi: 10.3390/antib7010003.
Antibodies (Basel). 2018.
PMID: 31544856
Free PMC article.
Item in Clipboard
Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies.
Dheilly E, Moine V, Broyer L, Salgado-Pires S, Johnson Z, Papaioannou A, Cons L, Calloud S, Majocchi S, Nelson R, Rousseau F, Ferlin W, Kosco-Vilbois M, Fischer N, Masternak K.
Dheilly E, et al. Among authors: majocchi s.
Mol Ther. 2017 Feb 1;25(2):523-533. doi: 10.1016/j.ymthe.2016.11.006.
Mol Ther. 2017.
PMID: 28153099
Free PMC article.
Item in Clipboard
MAR-Mediated transgene integration into permissive chromatin and increased expression by recombination pathway engineering.
Kostyrko K, Neuenschwander S, Junier T, Regamey A, Iseli C, Schmid-Siegert E, Bosshard S, Majocchi S, Le Fourn V, Girod PA, Xenarios I, Mermod N.
Kostyrko K, et al. Among authors: majocchi s.
Biotechnol Bioeng. 2017 Feb;114(2):384-396. doi: 10.1002/bit.26086. Epub 2016 Oct 3.
Biotechnol Bioeng. 2017.
PMID: 27575535
Free PMC article.
Item in Clipboard
Epigenetic regulatory elements associate with specific histone modifications to prevent silencing of telomeric genes.
Majocchi S, Aritonovska E, Mermod N.
Majocchi S, et al.
Nucleic Acids Res. 2014 Jan;42(1):193-204. doi: 10.1093/nar/gkt880. Epub 2013 Sep 25.
Nucleic Acids Res. 2014.
PMID: 24071586
Free PMC article.
Item in Clipboard
Transcription factor CTF1 acts as a chromatin domain boundary that shields human telomeric genes from silencing.
Esnault G, Majocchi S, Martinet D, Besuchet-Schmutz N, Beckmann JS, Mermod N.
Esnault G, et al. Among authors: majocchi s.
Mol Cell Biol. 2009 May;29(9):2409-18. doi: 10.1128/MCB.00779-08. Epub 2009 Mar 9.
Mol Cell Biol. 2009.
PMID: 19273604
Free PMC article.
Item in Clipboard
Cite
Cite